Michael Jarsch

979 total citations
38 papers, 814 citations indexed

About

Michael Jarsch is a scholar working on Molecular Biology, Genetics and Hematology. According to data from OpenAlex, Michael Jarsch has authored 38 papers receiving a total of 814 indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Molecular Biology, 11 papers in Genetics and 6 papers in Hematology. Recurrent topics in Michael Jarsch's work include RNA and protein synthesis mechanisms (15 papers), Bacterial Genetics and Biotechnology (11 papers) and Genomics and Phylogenetic Studies (9 papers). Michael Jarsch is often cited by papers focused on RNA and protein synthesis mechanisms (15 papers), Bacterial Genetics and Biotechnology (11 papers) and Genomics and Phylogenetic Studies (9 papers). Michael Jarsch collaborates with scholars based in United States, Germany and Switzerland. Michael Jarsch's co-authors include August Böck, Helmut Burtscher, Ulrich H. Weidle, H. Hummel, Christoph Keßler, Anton Haselbeck, Michael R. Brandt, Martin Lanzendörfer, David G. Jackson and Josef Altenbuchner and has published in prestigious journals such as Nucleic Acids Research, Blood and FEBS Letters.

In The Last Decade

Michael Jarsch

38 papers receiving 764 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael Jarsch United States 18 609 143 126 101 83 38 814
Mohammad S. Saedi United States 17 291 0.5× 67 0.5× 47 0.4× 78 0.8× 66 0.8× 26 856
Shiri Klein Israel 21 584 1.0× 49 0.3× 39 0.3× 125 1.2× 245 3.0× 38 1.2k
Stuart Kuhstoss United States 13 595 1.0× 150 1.0× 85 0.7× 77 0.8× 256 3.1× 15 861
Javier Lizardi Cervera Spain 16 570 0.9× 78 0.5× 19 0.2× 69 0.7× 68 0.8× 42 889
Lingbo Zhang China 14 398 0.7× 41 0.3× 22 0.2× 162 1.6× 83 1.0× 27 894
Toshie Iwai Japan 10 589 1.0× 48 0.3× 52 0.4× 22 0.2× 33 0.4× 15 670
Stéphanie Renaud Switzerland 14 566 0.9× 103 0.7× 24 0.2× 31 0.3× 143 1.7× 17 856
Laurie Feldman United States 16 303 0.5× 99 0.7× 14 0.1× 320 3.2× 149 1.8× 34 717
Judith Müller Germany 9 259 0.4× 51 0.4× 28 0.2× 25 0.2× 141 1.7× 10 410
C.D.O. Cooper United Kingdom 17 1.2k 2.0× 184 1.3× 21 0.2× 19 0.2× 187 2.3× 33 1.5k

Countries citing papers authored by Michael Jarsch

Since Specialization
Citations

This map shows the geographic impact of Michael Jarsch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Jarsch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Jarsch more than expected).

Fields of papers citing papers by Michael Jarsch

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Jarsch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Jarsch. The network helps show where Michael Jarsch may publish in the future.

Co-authorship network of co-authors of Michael Jarsch

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Jarsch. A scholar is included among the top collaborators of Michael Jarsch based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Jarsch. Michael Jarsch is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Doleschel, Dennis, Anne Rix, Susanne Arns, et al.. (2015). Erythropoietin Improves the Accumulation and Therapeutic Effects of Carboplatin by Enhancing Tumor Vascularization and Perfusion. Theranostics. 5(8). 905–918. 31 indexed citations
2.
Doleschel, Dennis, Olaf Mundigl, Felix Gremse, et al.. (2012). Targeted Near-Infrared Imaging of the Erythropoietin Receptor in Human Lung Cancer Xenografts. Journal of Nuclear Medicine. 53(2). 304–311. 24 indexed citations
3.
Lamon, Séverine, Sylvain Giraud, Léonie Egli, et al.. (2009). A high-throughput test to detect C.E.R.A. doping in blood. Journal of Pharmaceutical and Biomedical Analysis. 50(5). 954–958. 43 indexed citations
4.
Jarsch, Michael, Michael R. Brandt, Martin Lanzendörfer, & Anton Haselbeck. (2007). Comparative Erythropoietin Receptor Binding Kinetics of C.E.R.A. and Epoetin-β Determined by Surface Plasmon Resonance and Competition Binding Assay. Pharmacology. 81(1). 63–69. 58 indexed citations
5.
Jarsch, Michael, Michael R. Brandt, & Anton Haselbeck. (2006). Consumption of C.E.R.A. and Epoetin Beta in a Cellular Assay: UT-7 Consumption Model.. Blood. 108(11). 1578–1578. 1 indexed citations
6.
Burtscher, Helmut, et al.. (2002). Identification of rat pancreatic carcinoma genes associated with lymphogenous metastasis.. PubMed. 22(4). 2015–27. 30 indexed citations
7.
Burtscher, Helmut, et al.. (2001). Identification of metastasis-associated genes by transcriptional profiling of a pair of metastatic versus non-metastatic human mammary carcinoma cell lines.. PubMed. 21(3B). 1771–6. 18 indexed citations
8.
Sawers, R. Gary & Michael Jarsch. (1996). Alternative regulation principles for the production of recombinant proteins in Escherichia coli. Applied Microbiology and Biotechnology. 46(1). 1–9. 18 indexed citations
10.
Evans, Leslie, et al.. (1991). A complex family of class-II restriction endonucleases, DsaI–VI, in Dactylococcopsis salina. Gene. 97(1). 87–95. 15 indexed citations
11.
Reischl, Udo, et al.. (1990). McrI: a novel class‐II restriction endonuclease from Micrococcus cryophilus recognizing 5'‐CGRY/CG‐3'. FEBS Letters. 264(2). 218–222. 1 indexed citations
12.
Wagner, Ernst, Gerd Schmitz, Klaus Kaluza, et al.. (1990). BmyI, novelSduI isoschizomer fromBacillus mycoidesrecognizing 5′-GDGCH/C-3′. Nucleic Acids Research. 18(10). 3088–3088. 1 indexed citations
13.
14.
Kaluza, Klaus, et al.. (1990). RleAI: a novel class-IIS restriction endonuclease from Rhizobium leguminosarum recognizing. Gene. 95(1). 129–131. 4 indexed citations
15.
Tautz, Norbert, Klaus Kaluza, Bruno S. Frey, et al.. (1990). SgrAI, a novel class-II restriction endonuclease fromStreptomyces griseusrecognizing the octanucleotide sequence 5′-CR/CCGGYA-3′. Nucleic Acids Research. 18(10). 3087–3087. 21 indexed citations
16.
Bolton, Bryan J., Gerd Schmitz, Michael Jarsch, & Christoph Keßler. (1990). Aspl, a novel isoschizomer ofTht111I from Achromobacterspecies 699 recognizing 5′-GACN/NNGTC-3′. Nucleic Acids Research. 18(11). 3422–3422. 1 indexed citations
17.
Bolton, Bryan J., Hans-Joachim Höltke, Gerd Schmitz, Michael Jarsch, & Christoph Keßler. (1989). AspHI, a novel isoschizomer ofHgiAI fromAchromobacterspecies H recognizing 5′-GWGCW/C-3′. Nucleic Acids Research. 17(22). 9500–9500. 2 indexed citations
18.
Bolton, Bryan J., Gerd Schmitz, Michael Jarsch, & Christoph Keßler. (1989). Kspl, a novel isoschizomer ofSacIIfromKluyveraspecies recognizing 5′-CCGC/GG-3′. Nucleic Acids Research. 17(22). 9476–9476. 2 indexed citations
19.
Jarsch, Michael, et al.. (1988). AsnI: A novel class II restriction endonuclease from Arthrobacter sp., strain N‐CM, recognizing 5′‐AT/TAAT‐3′. FEBS Letters. 235(1-2). 241–246. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026